Dysfunction of pulmonary surfactant in chronically ventilated premature infants

Jeffrey D Merrill1, Roberta A Ballard, Avital Cnaan

  • 1Neonatology, Department of Pediatrics, University of Pennsylvania School of Medicine, USA.

Pediatric Research
|October 22, 2004
PubMed

Insights

Most premature infants needing respiratory support develop abnormal surfactant function due to deficiencies in surfactant proteins SP-B and SP-C. This dysfunction is linked to infection and respiratory decline, impacting long-term pulmonary health.

Area of Science:

  • Neonatal Medicine
  • Respiratory Physiology
  • Biochemistry

Background:

  • Premature infants (<30 wk gestation) often require prolonged respiratory support.
  • Bronchopulmonary dysplasia (BPD) is a significant risk in these infants, leading to long-term pulmonary issues or death.
  • Surfactant dysfunction is implicated in respiratory distress.

Purpose of the Study:

  • To investigate surfactant status in premature infants at high risk for BPD.
  • To identify factors associated with abnormal surfactant function in this population.

Main Methods:

  • Prospective analysis of 247 tracheal aspirate samples from 68 infants (23-30 wk gestation) intubated for 7-84 days.
  • Surfactant function assessed using a pulsating bubble surfactometer (minimum surface tension).
  • Surfactant protein (SP) A, B, and C levels measured by immunoassay in surfactant pellets.

Main Results:

  • 75% of infants exhibited abnormal surfactant function (elevated minimum surface tension).
  • Abnormal surfactant function correlated with infection (p=0.01) and respiratory deterioration (p=0.005).
  • Reduced levels of SP-A (50%), SP-B (80%), and SP-C (72%) were found in samples with abnormal surface tension. SP-B and SP-C content strongly correlated with surfactant function (p<0.0001).

Conclusions:

  • Premature infants requiring prolonged respiratory support frequently experience transient surfactant dysfunction.
  • This dysfunction is characterized by deficiencies in surfactant proteins SP-B and SP-C.
  • Surfactant protein deficiencies are linked to clinical events like infection and respiratory decline in high-risk infants.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...